FDA Clears BrainSpace Intellidrop to Automate ICU Neuro Care
SEATTLE, Jan. 2, 2026 — U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to BrainSpace for Intellidrop,...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
SEATTLE, Jan. 2, 2026 — U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to BrainSpace for Intellidrop,...
